𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Dopamine agonists and valvular heart disease in Japanese patients with Parkinson's disease

✍ Scribed by Masahiro Nagai; Noriko Nishikawa; Hayato Yabe; Hiroyoko Moritoyo; Takashi Moritoyo; Yuji Shigematsu; Masahiro Nomoto

Publisher
Springer
Year
2007
Tongue
English
Weight
242 KB
Volume
254
Category
Article
ISSN
0340-5354

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Valvular heart disease in Parkinson's di
Valvular heart disease in Parkinson's disease treated with ergot derivative dopamine agonists
✍ Ji-Youn Kim; Eun Joo Chung; Seung Woo Park; Won Yong Lee πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 105 KB

Valvular heart disease, associated with ergot derivative dopamine agonists, has been reported in patients with Parkinson's disease (PD). There are few comparative studies on the frequency, severity, and dose dependency of valvular disease associated with ergot derivatives. We analyzed these factors

Valvular heart disease in Parkinson's di
Valvular heart disease in Parkinson's disease patients treated with dopamine agonists: A reader-blinded monocenter echocardiography study
✍ Susann Junghanns; Joerg T. Fuhrmann; Gregor Simonis; Christian Oelwein; Rainer K πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 69 KB

## Abstract Fibrotic valvular heart disease (VHD) has been reported in association with ergot dopamine agonists (DAs), but the current database is insufficient regarding clinical relevance and comparison to data on non‐ergot DAs. We evaluated the effects of four DAs (pergolide, cabergoline, ropinir

The risk of valvular regurgitation in pa
The risk of valvular regurgitation in patients with Parkinson's disease treated with dopamine receptor agonists
✍ Vibeke Guldbrand Rasmussen; Karen Østergaard; Erik Dupont; Steen Hvitfeldt Pouls πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 217 KB πŸ‘ 1 views

## Abstract ## Objectives: Several observational studies suggest an association between treatment with ergoline‐derived dopamine agonists and valvular regurgitation. In this article, we present an overview of the literature and conduct a meta‐analysis. ## Methods: Observational studies addressin